Research focus
About the research
What role should surgery play in the management of early lung cancer detected by CT scan?
Read the full research overview
Nasser Altorki is the Chief of the Division of Thoracic Surgery at Weill Cornell Medicine. His clinical research interests include the treatment of locally advanced lung cancer and esophageal cancer. They also include the surgical treatment benign esophageal conditions such as achalasia and gastroesophageal reflux disease. His research interests include investigating the role of immunotherapy in treating various chest malignancies.
Selected publications
3 listedAdjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial
The Lancet
Lobar or Sublobar Resection for Peripheral Stage IA Non–Small-Cell Lung Cancer
New England Journal of Medicine
Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial
The Lancet Oncology
People & alumni
Team details haven’t been added. See the lab’s website for its current members.
Alumni details haven’t been added. Check the lab’s official website.
Sources & listing information
Find Research Labs maintains this page using public sources. The faculty member, lab, and university have not claimed or approved this listing. Listing a lab does not indicate endorsement, partnership, or a recruiting opportunity.
Request a correction or removal ↗ · About directory listings